The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Rocket Pharmaceuticals Inc (NASDAQ: RCKT) was $3.07 for the day, up 2.68% from the previous closing price of $2.99. In other words, the price has increased by $2.68 from its previous closing price. On the day, 2.33 million shares were traded. RCKT stock price reached its highest trading level at $3.08 during the session, while it also had its lowest trading level at $2.97.
Ratios:
Our analysis of RCKT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.19 and its Current Ratio is at 9.19. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On May 30, 2025, Evercore ISI Downgraded its rating to In-line which previously was Outperform but kept the price unchanged to $5.
Morgan Stanley Downgraded its Overweight to Equal-Weight on May 28, 2025, while the target price for the stock was maintained at $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 03 ’25 when Ondrey Aaron sold 1,477 shares for $2.88 per share. The transaction valued at 4,257 led to the insider holds 128,173 shares of the business.
Ondrey Aaron bought 1,477 shares of RCKT for $4,256 on Jul 03 ’25. On May 20 ’25, another insider, Militello John, who serves as the insider of the company, sold 357 shares for $6.45 each. As a result, the insider received 2,301 and left with 64,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 330755648 and an Enterprise Value of 37943412.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.62, which has changed by -0.8474913 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $22.01, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 0.75%, while the 200-Day Moving Average is calculated to be -65.42%.
Shares Statistics:
RCKT traded an average of 4.99M shares per day over the past three months and 2837010 shares per day over the past ten days. A total of 106.75M shares are outstanding, with a floating share count of 99.07M. Insiders hold about 8.05% of the company’s shares, while institutions hold 86.40% stake in the company. Shares short for RCKT as of 1752537600 were 12898169 with a Short Ratio of 2.58, compared to 1749772800 on 14041698. Therefore, it implies a Short% of Shares Outstanding of 12898169 and a Short% of Float of 23.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for Rocket Pharmaceuticals Inc (RCKT) is a result of the insights provided by 16.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.15 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$0.9 and -$2.42 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$1.17, with 16.0 analysts recommending between $1.76 and -$2.13.
